Other Parkinson syndromes

Neurologic Clinics

Volumn 19, Issue 3, 2001, Pages 629-649

  Colcher, Amy ^a,b   Simuni, Tanya ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; AMPHOTERICIN B; CALCIUM CHANNEL BLOCKING AGENT; DIMERCAPROL; FLUNARIZINE; FLUOXETINE; LITHIUM; METHYLDOPA; NEUROLEPTIC AGENT; PENICILLAMINE; PETHIDINE; PROCAINE; PYRIDOSTIGMINE; RESERPINE; TETRABENAZINE; TETRATHIOMOLYBDIC ACID; ZINC;

BRAIN FUNCTION; DIFFERENTIAL DIAGNOSIS; DOPAMINE METABOLISM; DRUG CLASSIFICATION; EPIDEMIC ENCEPHALITIS; GENETIC DISORDER; HALLERVORDEN SPATZ DISEASE; HUMAN; HUNTINGTON CHOREA; HYDROCEPHALUS; INJURY; LEWY BODY; MACHADO JOSEPH DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOMATOLOGY; WILSON DISEASE;

EID: 0034852358     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(05)70038-4     Document Type: Article

References (159)

1. CAG repeat number correlates with the rate of brain stem and cerebellar atrophy in Machado-Joseph disease
2. Parkinsonism secondary to bilateral striatal fungal abscesses
3. Use of carbidopa-levodopa in a patient with hydrocephalus and frozen movement
4. Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia
5. The natural history of Machado-Joseph disease. An analysis of 138 personally examined cases
6. Computed tomography in Hallervorden-Spatz disease
7. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990
8. Recognition, diagnosis, and management of Wilson's disease
9. The treatment of Wilson's disease
10. Hemiparkinsonism with hemiatrophy
11. Sequelae of epidemic encephalitis
12. L-dopa in postencephalitic parkinsonism
13. Late progression of post-encephalitic Parkinson's syndrome
14. Postencephalitic parkinsonism - A review
15. Drug-induced parkinsonism as a risk factor for Parkinson's disease: A historical cohort study in Olmsted County, Minnesota
16. A retinopathy on Guam with high prevalence in lyticobodig
17. Arteriosclerotic parkinsonism
18. Parkinsonian syndromes associated with hydrocephalus: Case reports, a review of the literature, and pathophysiological hypotheses
19. Neurofibrillary tangles in dementia pugilistica are ubiquitinated
20. The brain in older persons with and without dementia: Findings on MR, PET, and SPECT images
21. Wilson's disease (hepato-lenticular degeneration). Changing clinical concepts
22. Hallevorden-Spatz syndrome
23. What caused the 1918-1930 epidemic of encephalitis lethargica?
24. Imaging of the aging brain. Part II. Pathologic conditions
25. Response of patients with postencephalitic parkinsonism to levodopa
26. Encephalitis and parkinsonism
27. Adult onset Hallervorden-Spatz disease with neurofibrillary pathology
28. No viral antigens detected in brain tissue from a case of acute encephalitis lethargica and another case of post-encephalitic parkinsonism
29. Psychogenic movement disorders: Frequency, clinical profile, and characteristics
30. Trauma as an etiology of parkinsonism: A historical review of the concept
31. Prior history of head trauma in Parkinson's disease
32. Posttraumatic parkinsonism
33. Psychogenic dystonia
34. Predictability of phenotype in Huntington's disease
35. Parkinsonism and dilatation of the perivascular spaces (etat crible) of the striatum: A clinical, magnetic resonance imaging, and pathological study
36. Les syndromes parkinsoniens vasculaires: Un concept controverse
37. Wilson's disease
38. Lower body parkinsonism: Evidence for vascular etiology
39. Treatment of psychogenic movement disorders
40. Postencephalitic parkinsonism
41. Progressive parkinsonism in boxers
42. Arm tremor secondary to Wilson's disease
43. Psychogenic movement disorders
44. The prevalence of metoclopramideinduced tardive dyskinesia and acute extrapyramidal movement disorders
45. Drug-induced parkinsonism in the aged. Recognition and prevention
46. The progression of idiopathic Parkinson's disease is not explained by age-related changes. Clinical and pathological comparisons with post-encephalitic parkinsonian syndrome
47. Dementia, parkinsonism and motor neuron disease: Neurochemical and neuropathological correlates
48. Effects of head trauma from motor vehicle accidents on Parkinson's disease
49. Diagnosis of Wilson's disease: An experience over three decades
50. Late onset chorea with typical pathology of Hallervorden-Spatz syndrome
51. Neurological sequelae of boxing
52. Zur pathogenese des postencephalitis parkinsonisms
53. Machado-Joseph disease
54. Parkinsonism-dementia complex. An endemic disease on the island of Guam. II. Pathological features
55. Pathoanatomic changes in amyotrophic lateral sclerosis on Guam: Special reference to the occurrence of neurofibrillary changes
56. Amyotrophic lateral sclerosis and parkinsonismdementia from Guam: Differences in neurofibrillary tangle distribution and density in the hippocampal formation and neocortex
57. Dementia and motor neuron disease: Morphometric, biochemical and Golgi studies
58. Risk factors for Parkinson's disease
59. Amyotrophic lateral sclerosis and its association with dementia, parkinsonism, and other neurological disorders: A review
60. Vascular parkinsonism
61. Hydrocephalic parkinsonism due to Paget's disease of bone: Dramatic improvement following ventriculoperitoneal shunt and temporary levodopa/carbidopa therapy
62. Late-onset Hallervorden-Spatz syndrome presenting as familial parkinsonism
63. Parkinsonism and acquired hydrocephalus
64. Lower body (vascular) parkinsonism
65. Post-traumatic movement disorders: Central and peripheral mechanisms
66. The pathology of parkinsonism
67. Trauma as an etiologic agent in Parkinson's disease
68. Chronic traumatic brain injury associated with boxing
69. Clozapine, negative symptoms, and extrapyramidal side effects
70. Tremor as the result of shunt obstruction: Four patients with cysticercosis and secondary parkinsonism: Report of four cases
71. Liver transplantation for metabolic liver diseases
72. Pallidonigral pigmentation and spheroid formation with mutiple striatal lacunar infarcts
73. Prolonged drug-induced parkinsonism
74. Hemiparkinsonism as a late complication of hemiatrophy: A new syndrome
75. Senile gait: Correlation with computed tomographic scans
76. Posttraumatic movement disorders: A review
77. Movement disorders in adult hydrocephalus
78. Potential role of viruses in neurodegeneration
79. Historical review: Abnormal movements associated with epidemic encephalitis lethargica
80. Epidemiologic investigations of amyotrophic lateral sclerosis I. Preliminary report on geographic distribution, with special reference to the Mariana Islands, including clinical and pathologic observations
81. Psychogenic parkinsonism
82. Trauma and Parkinson's disease
83. Drug-induced parkinsonian syndromes: A 10-year experience at a regional center of pharmaco-vigilance
84. Psychogenic movement disorders
85. Spontaneous and drug-induced movement disorders
86. Drug-induced parkinsonism: A growing list
87. Cinnarizine-induced parkinsonism: Ten years later
88. Could Parkinson's disease follow intra-uterine influenza?: A speculative hypothesis
89. Influenza caused epidemic encephalitis (encephalitis lethargica): The circumstantial evidence and a challenge to the naysayers
90. Neurological Wilson's disease
91. Cognitive impairment in Wilson's disease
92. Neuropsychological impairment in Wilson's disease
93. Psychopathology in patients with Wilson's disease
94. Relationship between age and incidence of parkinsonism in psychiatric patients treated with haloperidol
95. Drug-induced parkinsonism: A review
96. Behavioural pharmacology of the new generation of antipsychotic agents
97. Characteristic magnetic resonance imaging findings in Machado-Joseph disease
98. Parkinsonism due to a basal ganglia lacunar state: Clinicopathologic correlation
99. The clinical course of epidemic encephalitis
100. Tetrabenazine treatment for tardive dyskinesia: Assessment by randomized videotape protocol
101. Parkinsonism: Natural history and clinical features
102. Pathogenesis of pigment and spheroid formation in Hallervorden-Spatz syndrome and related disorders
103. Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Clinical features and response to levodopa
104. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3
105. Basal ganglia damage and subcortical dementia after possible insidious Coxsackie virus encephalitis
106. Ataxin-3 with an altered conformation exposes that the polyglutamine domaine is associated with the nuclear matrix
107. Hallevorden-Spatz disease: Cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus
108. Wilson's disease
109. The present status of encephalitis lethargica
110. Metabolic topography of the hemi-parkinsonism-hemiatrophy syndrome
111. 1918 Influenza, encephalitis lethargica, parkinsonism
112. The occult aftermath of boxing
113. Wilson's disease
114. Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam: A 30-year evaluation of clinical and neuropathologic trends
115. Other central nervous system conditions that can cause or mimic parkinsonism
116. A high index of suspicion: The key to an early diagnosis of Wilson's disease in childhood
117. Parkinsonism secondary to neurosyphilis. A case report
118. Copper transport and its defect in Wilson's disease: Characterization of the copper-binding domain of Wilson's disease ATPase
119. Huntington acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
120. Relationship between structure and drug-induced parkinsonism
121. Magnetic resonance imaging in pathologically proven Hallevorden-Spatz disease
122. Machado-Joseph disease: A multisystem degenerative disorder of the nervous system
123. Investigating diseases no one's got
124. Wilson's disease and Kayser-Fleischer rings
125. Familial occurrence of amyotrophic lateral sclerosis, parkinsonism, and dementia
126. Sleep disturbance in spinocerebellar ataxias: Is the SCA3 mutation a cause of restless legs syndrome?
127. Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease
128. Hallervorden-Spatz syndrome: Clinical and magnetic resonance imaging correlations
129. Obstructive hydrocephalus-induced parkinsonism I: Decreased basal ganglia regional blood flow
130. Hydrocephalus and parkinsonism
131. Japanese encephalitis and parkinsonism
132. Parkinsonism with amyotrophy
133. Positron emission tomography in asymptomatic gene carriers of Machado-Joseph disease
134. Psychopharmacology of olanzapine. A review
135. Head trauma as a risk factor for Parkinson's disease
136. Epidemic encephalitis (encephalitis lethargica)
137. Viral etiology for Parkinson's disease - A possible role of influenza A virus infection
138. Parkinsonism in HIV encephalopathy
139. Environmental factors in the etiology of Parkinson's disease
140. Parkinsonism, dementia and gaze paresis in Chamorros on Guam: A progressive supranuclear palsy-like syndrome
141. Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13
142. Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger's disease
143. Medical complications of new antipsychotic drugs
144. Reversible parkinsonian syndrome complicating cysticercus midbrain encephalitis
145. Encephalitis lethargica
146. Widespread occurrence of alphasynuclein/NACP-immunoreactive neuronal inclusions in juvenile and adult-onset Hallervorden-Spatz disease with Lewy bodies
147. Wilson's disease HLD
148. Wilson's disease presenting with features of hepatic dysfunction: A clinical analysis of eighty-seven patients
149. Wilson's disease: Yesterday, today, and tomorrow
150. Brain injury and neurologic sequelae: A cohort study of dementia, parkinsonism and amyotrophic lateral sclerosis
151. Phenomenology and psychopathology related to psychogenic movement disorders
152. Epidemic encephalitis
153. Decreased dopamine transporter binding in Machado-Joseph disease
154. Parkinsonism associated with obstructive hydrocephalus due to idiopathic aquaductal stenosis
155. Late onset ataxia, rigidity, and peripheral neuropathy
156. MRI in patients with suspected vascular parkinsonism